Axcelis Corporate Controller Sells: Is ACLS Stock Worth It?
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesAn Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
The Federal Reserve's stress tests gave America's biggest banks a green light, and lenders quickly rewarded sharehold...
When a fintech stock investor trims a large stake in a rising Brazilian payments firm, traders and everyday investors...
A large insider sale often sparks questions about a company’s future. This article breaks down what the move means, h...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...